Patents by Inventor Ernst SHÖNBRUNN

Ernst SHÖNBRUNN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Potent dual BRD4-kinase inhibitors as cancer therapeutics
    Patent number: 10106507
    Abstract: Disclosed herein are compounds that are inhibitors of BRD4 and their use in the treatment of cancer. Methods of screening for selective inhibitors of BRD4 are also disclosed. In certain aspects, disclosed are compounds of Formula I-IV.
    Type: Grant
    Filed: August 3, 2015
    Date of Patent: October 23, 2018
    Assignee: H. Lee Moffitt Cancer Center and Research Insitute, Inc.
    Inventors: Ernst Shönbrunn, Nicholas J. Lawrence, Harshani R. Lawrence
  • POTENT DUAL BRD4-KINASE INHIBITORS AS CANCER THERAPEUTICS
    Publication number: 20170226065
    Abstract: Disclosed herein are compounds that are inhibitors of BRD4 and their use in the treatment of cancer. Methods of screening for selective inhibitors of BRD4 are also disclosed. In certain aspects, disclosed are compounds of Formula I-IV.
    Type: Application
    Filed: August 3, 2015
    Publication date: August 10, 2017
    Inventors: Ernst SHÖNBRUNN, Nicholas J. LAWRENCE, Harshani R. LAWRENCE